{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:vasculitis:buerger-disease",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-08T21:12:00.000Z",
    "updated": "2026-01-08T21:12:00.000Z",
    "contributors": ["copilot-agent"],
    "confidence": 0.91,
    "status": "draft",
    "review_status": "pending_review"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/vasculitis",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "high",
    "topic_id": "VASC-018"
  },
  "content": {
    "title": "Thromboangiitis Obliterans (Buerger Disease)",
    "definition": {
      "primary": "A non-atherosclerotic, segmental, inflammatory vasculitis affecting small and medium-sized arteries and veins of the upper and lower extremities, almost exclusively associated with tobacco use, characterized by distal ischemia, superficial thrombophlebitis, and Raynaud phenomenon.",
      "key_concepts": [
        "Strongly associated with tobacco/cannabis use - cessation essential for treatment",
        "Affects young patients (typically < 45 years) without atherosclerotic risk factors",
        "Involves both arteries and veins (distinguishing feature)",
        "Segmental, non-atherosclerotic occlusion with corkscrew collaterals"
      ]
    },
    "epidemiology": {
      "demographics": {
        "age": "Typically 20-45 years at onset",
        "gender": "Historically male predominant (10:1), but female incidence increasing with smoking",
        "geography": "Higher in Asia, Middle East, Eastern Europe"
      },
      "association_with_tobacco": {
        "prevalence": "Nearly 100% of patients are current or recent tobacco users",
        "dose_response": "More severe disease with heavier tobacco use",
        "other_exposures": "Cannabis, smokeless tobacco also implicated"
      }
    },
    "pathophysiology": {
      "mechanism": {
        "proposed": "Immunologically mediated reaction to tobacco antigens in genetically susceptible individuals",
        "inflammatory_phase": [
          "Highly cellular thrombus with polymorphonuclear cells",
          "Microabscess formation in thrombus (pathognomonic)",
          "Intact internal elastic lamina (distinguishes from atherosclerosis)",
          "Perivascular fibrosis"
        ],
        "chronic_phase": [
          "Organized thrombus",
          "Recanalization channels",
          "Progressive fibrosis"
        ]
      },
      "vessels_affected": [
        "Small and medium arteries (tibial, radial, ulnar, digital)",
        "Superficial veins (migratory thrombophlebitis)",
        "Spares large arteries (femoral, brachial usually normal)"
      ]
    },
    "clinical_presentation": {
      "arterial_manifestations": [
        {
          "manifestation": "Digital ischemia",
          "description": "Finger or toe ischemia with rest pain, ulceration, gangrene",
          "pattern": "Distal predominance, often multiple digits"
        },
        {
          "manifestation": "Claudication",
          "description": "Foot, calf, forearm claudication",
          "characteristic": "Instep claudication pathognomonic"
        },
        {
          "manifestation": "Raynaud phenomenon",
          "frequency": "40-50% of patients"
        }
      ],
      "venous_manifestations": [
        {
          "manifestation": "Superficial thrombophlebitis",
          "pattern": "Migratory, recurring in different locations",
          "frequency": "40-60% of patients"
        }
      ],
      "phases_of_disease": [
        "Active phase: New ischemia, active inflammation",
        "Quiescent phase: Stable disease with tobacco cessation",
        "Recurrent phase: Flare with tobacco re-exposure"
      ]
    },
    "diagnosis": {
      "clinical_criteria": {
        "diagnostic_features": [
          "Age < 45 years at onset",
          "Current or recent tobacco use",
          "Distal extremity ischemia (claudication, rest pain, ulcers, gangrene)",
          "Exclusion of atherosclerosis, diabetes, embolic sources",
          "Absence of proximal embolic source",
          "Consistent arteriographic findings"
        ],
        "supportive_features": [
          "Superficial migratory thrombophlebitis",
          "Raynaud phenomenon",
          "Upper extremity involvement"
        ]
      },
      "diagnostic_workup": [
        {
          "test": "Arteriography",
          "findings": [
            "Segmental occlusions in distal vessels",
            "'Corkscrew' collaterals (pathognomonic)",
            "Proximal vessels typically normal",
            "Abrupt vessel cutoffs"
          ]
        },
        {
          "test": "Laboratory",
          "findings": "Normal inflammatory markers (ESR, CRP), negative autoimmune workup",
          "purpose": "Exclude other vasculitides, autoimmune disease"
        },
        {
          "test": "Echocardiography",
          "purpose": "Exclude cardiac embolic source"
        },
        {
          "test": "Thrombophilia workup",
          "purpose": "Exclude hypercoagulable states"
        }
      ],
      "differential_diagnosis": [
        "Atherosclerotic PAD (older patients, proximal disease)",
        "Embolic disease (irregular cutoffs, cardiac source)",
        "Scleroderma/CREST syndrome",
        "Takayasu arteritis (large vessel involvement)",
        "Antiphospholipid syndrome"
      ]
    },
    "management": {
      "essential_intervention": {
        "tobacco_cessation": {
          "importance": "Absolutely essential - disease progression virtually ceases with cessation",
          "all_forms": "Must stop cigarettes, cigars, pipes, smokeless tobacco, cannabis",
          "outcome_with_cessation": "94% amputation-free survival if complete cessation",
          "outcome_without": "43% require amputation with continued smoking"
        }
      },
      "medical_therapy": {
        "proven_benefit": [
          "Tobacco cessation (cornerstone)",
          "Calcium channel blockers (for Raynaud)",
          "Aspirin (antiplatelet)",
          "Wound care, infection prevention"
        ],
        "variable_benefit": [
          {
            "therapy": "Iloprost (prostacyclin analog)",
            "evidence": "RCT showing improved ulcer healing, pain relief",
            "administration": "IV infusion"
          },
          {
            "therapy": "Cilostazol",
            "evidence": "Limited data in Buerger disease specifically"
          }
        ],
        "unproven": [
          "Pentoxifylline",
          "Anticoagulation",
          "Immunosuppression"
        ]
      },
      "surgical_options": {
        "revascularization": {
          "feasibility": "Limited by distal disease and small vessel involvement",
          "options": [
            "Bypass surgery (rarely possible, poor targets)",
            "Endovascular intervention (limited role)"
          ],
          "outcome": "Poor patency rates in those who continue smoking"
        },
        "sympathectomy": {
          "type": "Thoracic (upper extremity) or lumbar (lower extremity)",
          "role": "May improve rest pain, promote wound healing",
          "evidence": "Variable outcomes, mostly uncontrolled studies"
        },
        "amputation": {
          "indication": "Refractory rest pain, non-healing ulcers, infection, gangrene",
          "level": "Often digital or transmetatarsal if possible"
        }
      },
      "experimental_therapies": [
        "Autologous bone marrow cell implantation (angiogenesis)",
        "Gene therapy (VEGF)",
        "Spinal cord stimulation"
      ]
    },
    "prognosis": {
      "with_tobacco_cessation": {
        "amputation_rate": "< 6% over 5-7 years",
        "disease_progression": "Virtually stops"
      },
      "without_cessation": {
        "amputation_rate": "40-50% over similar period",
        "mortality": "Higher due to cardiovascular complications"
      },
      "mortality": "Not directly fatal, but associated with increased cardiovascular mortality"
    }
  },
  "relationships": {
    "requires": [
      "vascular:diagnostics:angiography",
      "vascular:pathophysiology:vasculitis"
    ],
    "related_to": [
      "vascular:vasculitis:takayasu-arteritis",
      "vascular:ue:digital-ischemia"
    ]
  },
  "educational": {
    "learning_objectives": [
      "Recognize clinical features suggesting Buerger disease",
      "Apply diagnostic criteria to differentiate from atherosclerotic PAD",
      "Identify pathognomonic arteriographic findings",
      "Understand the critical importance of tobacco cessation",
      "Select appropriate medical and surgical management"
    ],
    "key_points": [
      "Tobacco cessation is the only proven treatment to halt disease progression",
      "Affects young patients without traditional atherosclerotic risk factors",
      "Involves both arteries and veins (migratory thrombophlebitis)",
      "Corkscrew collaterals on arteriography are pathognomonic",
      "Prognosis is excellent with smoking cessation, poor without"
    ],
    "clinical_pearls": [
      "Think of Buerger disease in a young smoker with digital ischemia and normal proximal pulses",
      "Ask about cannabis use - also implicated in disease pathogenesis",
      "Superficial thrombophlebitis in young smoker is red flag",
      "Instep claudication is highly characteristic"
    ]
  },
  "references": {
    "evidence_basis": "Clinical series, RCTs for iloprost, observational studies",
    "terminology": {
      "snomed_ct": "50685005",
      "icd10": "I73.1"
    }
  }
}
